We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Lumos Pharma Inc | NASDAQ:LUMO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.03 | -1.20% | 2.48 | 2.00 | 16.50 | 2.51 | 2.43 | 2.48 | 5,336 | 05:00:01 |
H.C. Wainwright 25th Annual Global Investment Conference: September 11th – 13th
Title: | Lumos Pharma Corporate Presentation (On-Demand) | |
Date/Time: | September 11th at 7:00AM EDT | |
Webcast Link: | Register here | |
Cantor Global Healthcare Conference 2023: September 26th -28th
Title: | Lumos Pharma Fireside Chat | |
Date/Time: | September 28th at 1:15PM EDT | |
Webcast Link: | Register here | |
The webcasts for both conferences can also be found on the Company’s website under Events & Presentations in the Investors & Media section. A replay of both presentations will be available for 90 days thereafter. Please contact your conference salesperson or Lumos Pharma Investor Relations to schedule one-on-one meetings with the management team.
About Lumos Pharma
Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. The Company was founded and is led by a management team with longstanding experience in rare disease drug development. Lumos Pharma’s lead therapeutic candidate, LUM-201, is a novel, oral growth hormone (GH) secretagogue, seeking to transform the $4.5B global GH market from injectable to oral therapy. LUM-201 is currently being evaluated in multiple Phase 2 clinical studies in Pediatric Growth Hormone Deficiency (PGHD) and has received Orphan Drug Designation in both the US and EU. For more information, please visit https://lumos-pharma.com/.
Investor & Media Contact:
Lisa MillerLumos Pharma Investor Relations512-792-5454ir@lumos-pharma.com
1 Year Lumos Pharma Chart |
1 Month Lumos Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions